Loading
Latest filing published 25 Sept 2025 for Rentokil Initial plc, €37k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Andy Ransom appears in our data through filings on Rentokil Initial plc shares, published by RNS (LSE). Between 8 March 2018 and 23 September 2025, the trades on record add up to 12 filings.
Market trades split into 2 purchases (€523k) and 3 sales (€5.1M). The net balance comes to €4.6M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 share grants and 3 option exercises. In 2025 alone, the filings show no purchases and 1 sale.
The record was last updated on 25 September 2025 with a share grant (€37k) in Rentokil Initial plc. The last purchase on record was published on 3 November 2023, which is 1,086 days ago. Between a trade and the moment it shows up on RNS (LSE), the median delay is 1 day. For comparison, UK MAR gives managers three business days to notify a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations